KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ginkgo Bioworks Holdings (DNA) Gross Margin (2020 - 2025)

Historic Gross Margin for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to 78.95%.

  • Ginkgo Bioworks Holdings' Gross Margin fell 98400.0% to 78.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 81.66%, marking a year-over-year decrease of 45200.0%. This contributed to the annual value of 83.02% for FY2024, which is 15200.0% up from last year.
  • According to the latest figures from Q3 2025, Ginkgo Bioworks Holdings' Gross Margin is 78.95%, which was down 98400.0% from 80.97% recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Gross Margin registered a high of 102.5% during Q4 2023, and its lowest value of 156.28% during Q1 2023.
  • In the last 5 years, Ginkgo Bioworks Holdings' Gross Margin had a median value of 9.15% in 2021 and averaged 3.25%.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Gross Margin crashed by -1244400bps in 2023, and later skyrocketed by 2320200bps in 2024.
  • Quarter analysis of 5 years shows Ginkgo Bioworks Holdings' Gross Margin stood at 9.15% in 2021, then plummeted by -1127bps to 112.28% in 2022, then surged by 191bps to 102.5% in 2023, then fell by -19bps to 82.77% in 2024, then decreased by -5bps to 78.95% in 2025.
  • Its last three reported values are 78.95% in Q3 2025, 80.97% for Q2 2025, and 83.53% during Q1 2025.